跳至主要内容
临床试验/ACTRN12616001251415
ACTRN12616001251415招募中未知

M-Health: Efficacy and Cost-effectiveness of a smartphone App to reduce distress and unmet needs in people with cancer (ACE): a randomized controlled trial.

Deakin University - Professor Trish Livingston0 个研究点目标入组 250 人开始时间: 2016年9月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adults, aged 18+ years, who are newly diagnosed cancer patients - all cancer types comprising both solid tumors and haematological cancers - with curative intent (stages 1-3), attending day oncology centers for cycle 2-5 of adjuvant chemotherapy or fraction 2-5 for radiotherapy treatment for cancer; who are able to complete English language questionnaires; and have access to a Smartphone or similar tablet device (Android or iOS).

排除标准

  • Cognitive dysfunction of the cancer patient. Experienced health service oncology nurses will determine cognitive dysfunction, defined as overt psychotic illness or dementia.

研究者

发起方
Deakin University - Professor Trish Livingston

相似试验